Microbot Medical Inc Asset Resilience Ratio
Microbot Medical Inc asset resilience ratio. Microbot Medical Inc (MBOT) has an Asset Resilience Ratio of 88.19% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Microbot Medical Inc to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Microbot Medical Inc (1998–2025)
Asset resilience ratio of Microbot Medical Inc from 1998 to 2025. This chart shows how Microbot Medical Inc's Asset Resilience Ratio has changed over time. Read MBOT current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Microbot Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Microbot Medical Inc's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $68.84 Million | 88.19% |
| Total Liquid Assets | $68.84 Million | 88.19% |
Asset Resilience Insights
- Very High Liquidity: Microbot Medical Inc maintains exceptional liquid asset reserves at 88.19% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Microbot Medical Inc Industry Peers by Asset Resilience Ratio
Compare Microbot Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Microbot Medical Inc Asset Resilience Ratio by Year (1998–2025)
Microbot Medical Inc asset resilience ratio by year from 1998 to 2025. The table below shows the annual Asset Resilience Ratio data for Microbot Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 91.58% | $74.68 Million | $81.54 Million | +52.52pp |
| 2024-12-31 | 39.06% | $2.36 Million | $6.03 Million | -7.97pp |
| 2023-12-31 | 47.04% | $3.92 Million | $8.33 Million | -13.36pp |
| 2022-12-31 | 60.40% | $5.76 Million | $9.54 Million | +48.47pp |
| 2021-12-31 | 11.92% | $2.00 Million | $16.77 Million | -7.10pp |
| 2020-12-31 | 19.02% | $5.00 Million | $26.28 Million | +12.23pp |
| 2019-12-31 | 6.79% | $2.52 Million | $37.13 Million | +6.55pp |
| 2017-12-31 | 0.25% | $27.00K | $11.02 Million | -14.75pp |
| 2016-12-31 | 14.99% | $505.00K | $3.37 Million | +70.01pp |
| 2015-12-31 | -55.02% | $-11.67 Million | $21.22 Million | -55.02pp |
| 2014-12-31 | 0.00% | $-397.00 | $32.43 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $41.56 Million | -- |
| 2012-12-31 | 46.07% | $13.90 Million | $30.17 Million | +33.06pp |
| 2011-12-31 | 13.02% | $3.28 Million | $25.21 Million | +12.39pp |
| 2010-12-31 | 0.62% | $190.80K | $30.60 Million | +0.24pp |
| 2009-12-31 | 0.38% | $197.00K | $51.19 Million | -9.76pp |
| 2008-12-31 | 10.14% | $4.18 Million | $41.23 Million | -45.15pp |
| 2007-12-31 | 55.29% | $26.70 Million | $48.28 Million | +49.11pp |
| 2006-12-31 | 6.18% | $4.13 Million | $66.86 Million | -48.71pp |
| 2000-12-31 | 54.90% | $16.36 Million | $29.79 Million | +26.02pp |
| 1998-12-31 | 28.88% | $9.50 Million | $32.90 Million | -- |
About Microbot Medical Inc
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, periph… Read more